ÂÜÀòÂÒÂ×

Melanie is an experienced governance and corporate operations professional and non-executive director with 13+ years experience in listed life sciences companies and strong track record in the planning, management and delivery of strategic corporate activities including IPO and M&A due diligence and integration. Prior roles include with Factor Therapeutics Limited (ASX: FTT), Invion Limited (ASX: IVX), Menzies Research Centre, HRH The Prince of Wales’s Office, Global Asset Management, Imperial Cancer Research Fund, and The Prince’s Foundation. Melanie holds a Bachelor of Communication (Public Relations), and a Graduate Diploma in Applied Corporate Governance. She is a Fellow of the Governance Institute of Australia, a Fellow of the Chartered Governance Institute (UK) and a Graduate of the Australian Institute of Company Directors.